Is the WHO analgesic ladder still valid? Twenty-four years of experience;L'Échelle analgésique de l'OMS convient-elle toujours? Vingt-quatre années d'expérience

Canadian Family Physician

Volumn 56, Issue 6, 2010, Pages

  Vargas Schaffer, Grisell ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Pain Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUPRENORPHINE; CANNABINOID; GABAPENTIN; HYDROMORPHONE; HYPNOTIC AGENT; METHADONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXYCODONE; PREGABALIN; SODIUM CHANNEL BLOCKING AGENT; STEROID; TRAMADOL;

ADD ON THERAPY; CANCER PAIN; CLINICAL EXAMINATION; EXPERIENCE; HUMAN; MEDICAL STAFF; NEUROPATHIC PAIN; NOTE; PAIN; PAIN ASSESSMENT; PRESCRIPTION; TREATMENT DURATION; WORLD HEALTH ORGANIZATION;

ADMINISTRATION, ORAL; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; HUMANS; NEOPLASMS; NEURALGIA; PAIN; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 77953799914     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (35)

1. Organisation mondiale de la Santé. Traitement de la douleur cancéreuse. Genève, Suisse: Organisation mondiale de la Santé; 1987.
2. Organisation mondiale de la Santé. Traitement de la douleur cancéreuse. Genève, Suisse: Organisation mondiale de la Santé; 1997.
3. Azevedo São Leão Ferreira K, Kimura M, Jacobsen-Teixeira M. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? Support Care Cancer 2006;14(11):1086-93. Cyberpub. 8 juin 2006.
4. Zernikow B, Smale H, Michel E, Hasan C, Jorch N, Andler W. Paediatric cancer pain management using the WHO analgesic ladder - results of a prospective analysis from 2265 treatment days during a quality improvement study. Eur J Pain 2006;107):587-95. Cyberpub. 21 oct. 2005. (Pubitemid 44278715)
5. Vadalouca A, Moka E, Argyra E, Sikioti P, Siafaka I. Opioid rotation in patients with cancer: a review of the literature. J Opioid Manag 2008;4(4):213-50.
6. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA 1995;274(23):1870-3.
7. Kanpolat Y. Percutaneous destructive pain procedures on the upper spinal cord and brain stem in cancer pain: CT-guided techniques, indications and results. Adv Tech Stand Neurosurg 2007;32:147-73.
8. Lema MJ. Invasive procedures for cancer pain. Pain Clin Update 1998;6(1):1-8.
9. Krakowski I. 1986-1996: dix ans d'échelle OMS. Dans: Boiron M, Marty M, rédacteurs. Eurocancer 96. Montrouge, Fr: John Libbey Eurotext; 1996. p. 291-3.
10. Eisenberg E, Marinangeli F, Birkhahm J, Paladín A, Varrassi G. Time to modify the WHO analgesic leader? Pain Clin Update 2005;13(5):1-4.
11. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief: a 10 year prospective study. Pain 1995;63(1):65-76.
12. Araujo AM, Gomez M, Pascual J, Castañeda M, Pezonaga L, Borque JL. [Treatment of pain in oncology patients.] An Sist Sanit Navar 2004;27(Suppl 3):63-75. [Article en espagnol].
13. Miguel R. Interventional treatment of cancer pain: the fourth step in the world Health Organization analgesic ladder? Cancer Control 2000;7(2):149-56. (Pubitemid 30196852)
14. Gómez-Cortéz MD, Rodríguez-Huertas F. Reevaluación del segundo escalón de la escalera analgésica de la OMS. Rev Soc Esp Dolor 2000;7(6):343-4.
15. Vargas-Schaffer G. Manejo y tratamiento del dolor oncológico. Dans: Vargas-Schaffer G, Esposito Quercia G, rédacteurs. Dolor y cuidados paliativos en oncologia. evaluación, manejo y tratamiento. Caracas, Venezuela: Ediciones Expansión Científica G&S; 1999. p. 79-93.
16. Vargas-Schaffer G. Tratamiento del dolor oncologico y cuidados paliativos en pediatría. Dans: Morales Pola EA, rédacteur. Manual de clinica del dolor y cuidados paliativos. Chiapas, Mexique: Universidad autonoma de Chiapas; 2002. p. 195-206.
17. Krakowski I, Falcoff H, Gestin Y, Goldberg J, Guillain H, Jaulmes F, et al. Recommandation pour une bonne pratique dans la prise en charge de la douleur du cancer chez l'adulte et l'enfant. Nice, Fr: Societé française de la Douleur, Agency for Health Care Policy and Research; 1998. p. 11-5.
18. Torres LM, Calderon E, Pernia A, Martinez-Vasquez J, Mico JA. De la escalera al ascensor. Rev Soc Esp Dolor 2002;9(5):289-90.
19. Vargas-Schaffer G, Gonzalez de Mejia N, Castejon J, Fuenmayor F. Tratamiento del dolor en el paciente pediátrico. Consideraciones generales. Arch Venez Pueric Pediatr 2002;65(Suppl 1):S5-9.
20. Cahana A, Mavrocordatos P, Geurts JW, Groen GJ. Do minimally invasive procedures have a place in the treatment of chronic low back pain? Expert Rev Neurother 2004;4(3):479-90. (Pubitemid 38607913)
21. Vargas-Schaffer G. Fármacos empleados en los bloqueos anestésicos y analgésicos. Dans: Vargas-Schaffer G, Gonzalez de Mejia N, rédacteurs. Manual de bloqueos anestésicos y analgésicos en pediatría. Caracas, Venezuela: Ediciones Expansión Científica G&S 2002. p. 41-72.
22. Jovey R., Ennis J, Gardner J, Goldman B, Hays H, Lynch M, et al. Use of opioid analgesics for the treatment of chronic noncancer pain - a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manag 2003;8(Suppl A):3A-15A (ang), 16A-28 (fr).
23. Cerdá-Olmedo G, Monsalve V, Mínguez A, Valía JC, de Andrés JA. Algoritmo de decisión para el tratamiento del dolor crónico: una propuesta necesaria. Rev Soc Esp Dolor 2000;7(4):225-33.
24. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997;13(1):6-8.
25. Collège des Médecins du Québec. Treating pain: an update on the use of narcotics. Montréal, QC: Collège des Médecins du Québec; 2002.
26. Vargas-Schaffer G. Los opioides en el tratamiento del dolor. Rev Venez Anest 2002;7(1):30-41.
27. Vargas-Schaffer G, Godoy D. Conceptos básicos del uso de opioides en el tratamiento del dolor oncológico. Rev Venez Oncol 2004;16(2):103-14.
28. Bruera E, Palmer JL, Bosnjak S, Rico MA, Moyano J, Sweeney C, et al. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized double-blind study. J Clin Oncol 2004;22(1):185-92.
29. Tramèr MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 2001;323:(7303):16-21. (Pubitemid 32681999)
30. Clark AJ, Lynch ME, Ware M, Beaulieu P, McGilveray IJ, Gourlay D. Guidelines for the use of cannabinoid compounds in chronic pain. Pain Res Manage 2005;10(Suppl A):44A-6A. (Pubitemid 44796354)
31. Durán M, Capelà D. Cannabis y canabinoides en el tratamiento del dolor neuropático. Dolor 2005;20:219-22.
32. Berlach DM, Shir Y, Ware MA. Experience with the synthetic cannabinoid nabilone in chronic noncancer pain. Pain Med 2006;7(1):25-9. (Pubitemid 43337701)
33. Frank B, Serpell MG, Huges J, Matthews JN, Kapur D. Comparison of analgesic effects and patients tolerability of nabilone and hydrocodeine for chronic neuropathic pain: randomized, crossover, double blind study. BMJ 2008;336:199-201. DOI: 10.1136/bmj39429.619653.80. (Pubitemid 351212676)
34. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132(3):237-51. Cyberpub. 24 oct. 2007. DOI: 10.1016/j.pain.2007.08.033.
35. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007;12(1):13-21.